Search

691 Result(s)
Sort by

Immuno-Oncology

Immuno-Oncology

We are developing complementary platforms (including, T Cell Engagers, oncolytic viruses, and cancer vaccines), which have the potential to turn cold tumors hot, extending the benefits of immunotherapy to more people.
Our Partners_ViraTherapeutics

Our Partners_ViraTherapeutics

Lisa Egerer, COO and Patrik Erlman, Head of Research at ViraTherapeutics talk about their partnering journey with Boehringer Ingelheim.
Our people

Our people

Ambition. Passion. Integrity. Commitment. Empathy. Individuality. We expect these qualities at all levels.
Reggie the Red Blood Cell

Reggie the Red Blood Cell

Join Reggie, our curious red blood cell, on a journey exploring connections between the heart, kidneys and pancreas.
Bernard Mental Health Impact

Bernard Mental Health Impact

Harold and Friends learn about how living with multiple health conditions can impact mental health
Bok Oh

Bok Oh

Touching millions of lives with Bok Oh
Oliver Sluke

Oliver Sluke

Oliver Sluke on global business with a world of perspectives
History video

History video

Learn more about the history of the innovative pharmaceutical company Boehringer Ingelheim
Veganism

Veganism

Hear an expert’s opinion on the proposed link between a vegan diet and cancer recurrence rates.
Roasted Eggplant Fan Video

Roasted Eggplant Fan Video

Find out how this simple plant-based meal from Taking Cancer on Through Flavour and Taste Life are made
Four Pillars Cancer Immunology

Four Pillars Cancer Immunology

Boehringer Ingelheim is focusing cancer immunology research on T cell engagers, cancer vaccines, oncolytic viruses and immune & stromal modulation
FOYA_Shanghai

FOYA_Shanghai

Boehringer Ingelheim’s commercial manufacturing facility in Shanghai has been awarded as “Facility of the Year”